Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bethany J. Cavanagh currently holds 51,171 shares of Beam Therapeutics Inc. (BEAM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bethany J. Cavanagh has been a net seller of BEAM stock. They have purchased $0 and sold $91.1K worth of shares.
Bethany J. Cavanagh's most recent insider trade was on Apr 1, 2026, when they sold 3,242 shares at $24.58 per share.
Bethany J. Cavanagh serves as Executive at Beam Therapeutics Inc. (BEAM). They have executed 3 insider transactions totaling $91.1K over their tenure at the company.
Bethany J. Cavanagh holds the position of Executive at Beam Therapeutics Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 2 years and currently hold a stake valued at $0.
Bethany J. Cavanagh has shown a selling trading pattern, with $0 in total purchases and $91.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Bethany J. Cavanagh was on Apr 1, 2026, when they sold $79.7K worth of BEAM shares. This transaction involved 3,242 shares at $24.58 per share.
Bethany J. Cavanagh currently owns 51,171 shares of Beam Therapeutics Inc. (BEAM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bethany J. Cavanagh's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bethany J. Cavanagh has 3 Form 4 filings on record as an insider at Beam Therapeutics Inc..
Set alerts for Bethany J. Cavanagh and 40,000+ other insiders.